INGN Inogen Inc
Price (delayed)
$7.2
Market cap
$191.01M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.52
Enterprise value
$93M
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental
Highlights
Inogen's EPS has soared by 66% YoY and by 32% from the previous quarter
Inogen's net income has soared by 65% YoY and by 32% from the previous quarter
The quick ratio has contracted by 18% YoY and by 12% from the previous quarter
The equity has declined by 15% year-on-year and by 6% since the previous quarter
Key stats
What are the main financial stats of INGN
Market
Valuations
Earnings
Shares outstanding
26.53M
Market cap
$191.01M
Enterprise value
$93M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
0.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
Revenue
$335.71M
Gross profit
$154.74M
Operating income
-$42.52M
Net income
-$35.89M
EBIT
-$36.48M
EBITDA
-$15.47M
Free cash flow
-$11.18M
Per share
Balance sheet
Liquidity
EPS
-$1.52
EPS diluted
-$1.52
Free cash flow per share
-$0.47
Book value per share
$7.3
Revenue per share
$14.19
TBVPS
$10.83
Total assets
$296.19M
Total liabilities
$122.33M
Debt
$19.41M
Equity
$173.86M
Working capital
$108.77M
Debt to equity
0.11
Current ratio
2.42
Quick ratio
1.92
Net debt/EBITDA
6.33
Margins
Efficiency
Dividend
EBITDA margin
-4.6%
Gross margin
46.1%
Net margin
-10.7%
Operating margin
-12.7%
Return on assets
-11.7%
Return on equity
-19.4%
Return on invested capital
-35.7%
Return on capital employed
-16.6%
Return on sales
-10.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INGN stock price
How has the Inogen stock price performed over time
Intraday
3.6%
1 week
0.42%
1 month
-13.57%
1 year
1.55%
YTD
-21.48%
QTD
0.98%
Financial performance
How have Inogen's revenue and profit performed over time
Revenue
$335.71M
Gross profit
$154.74M
Operating income
-$42.52M
Net income
-$35.89M
Gross margin
46.1%
Net margin
-10.7%
The net margin has soared by 67% year-on-year and by 33% since the previous quarter
Inogen's net income has soared by 65% YoY and by 32% from the previous quarter
The operating margin has soared by 63% YoY and by 30% from the previous quarter
INGN's operating income has surged by 61% year-on-year and by 29% since the previous quarter
Growth
What is Inogen's growth rate over time
Valuation
What is Inogen stock price valuation
P/E
N/A
P/B
0.99
P/S
0.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
Inogen's EPS has soared by 66% YoY and by 32% from the previous quarter
INGN's P/B is 44% below its 5-year quarterly average of 1.7 and 14% below its last 4 quarters average of 1.1
The equity has declined by 15% year-on-year and by 6% since the previous quarter
The stock's price to sales (P/S) is 71% less than its 5-year quarterly average of 1.7 and 18% less than its last 4 quarters average of 0.6
The revenue has increased by 6% year-on-year
Efficiency
How efficient is Inogen business performance
Inogen's ROS has soared by 66% YoY and by 32% from the previous quarter
Inogen's ROA has soared by 59% YoY and by 30% from the previous quarter
INGN's ROIC has soared by 54% YoY and by 28% from the previous quarter
Inogen's return on equity has surged by 53% YoY and by 29% QoQ
Dividends
What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INGN.
Financial health
How did Inogen financials performed over time
INGN's total assets is 142% greater than its total liabilities
The quick ratio has contracted by 18% YoY and by 12% from the previous quarter
The company's current ratio fell by 15% YoY and by 9% QoQ
The debt is 89% smaller than the equity
The equity has declined by 15% year-on-year and by 6% since the previous quarter
The debt has declined by 11% year-on-year and by 3.7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.